| Document |
Document Title |
|
WO/2021/215446A1 |
This compound is represented by general formula (1). In general formula (1), X1 is CR1 or a nitrogen atom, X2 is CR2 or a nitrogen atom, X3 is CR3 or a nitrogen atom, X4 is CR4 or a nitrogen atom, X5 is CR5 or a nitrogen atom, X6 is CR6 ...
|
|
WO/2021/213358A1 |
Provided in the present invention are boron-containing compounds as represented by formula (I) or pharmaceutically acceptable salts thereof, pharmaceutical compositions including same, and an application of serving as a selective estroge...
|
|
WO/2021/214309A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule is represented by the following formula (I), wherein: n = 0 or 1; and X is at sel...
|
|
WO/2021/211741A1 |
Compounds having the structure of Formula (I) or pharmaceutically acceptable isomers, racemates, hydrates, solvates or salts thereof, where A, R1, R2a, R2b, R2c and R3 are as defined herein, are useful in the modulation of IL-12, IL-23 a...
|
|
WO/2021/210894A1 |
The present invention relates to a boron compound expressed by any one chemical formula from among chemical formulas A to E, and an organic light-emitting element comprising the boron compound, the chemical formulas A to E being as descr...
|
|
WO/2021/210501A1 |
The present invention provides a compound represented by formula (I) (wherein X, Y, and Z are each independently a hydrogen atom or an (un)substituted nitrogen-containing heteroaryl group but Y and/or Z is an (un)substituted nitrogen-con...
|
|
WO/2021/207352A1 |
Embodiments of the instant disclosure relate to novel methods and compositions for treating tumors resistant to one or more anticancer drugs, such as platinum-based chemotherapeutics.
|
|
WO/2021/204646A1 |
The present invention relates to polycyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2021/198509A1 |
The invention relates to a process for preparing a boronic anhydride compound of formula (1), wherein, R1 - R4 are substituents as defined in the disclosure and 'B' stands for the element boron. The invention also describes a process of ...
|
|
WO/2021/201054A1 |
This non-aqueous electrolyte for batteries contains a phosphazene compound (A) including at least one among a phosphazene compound represented by formula (1) and a phosphazene compound represented by formula (2). In formulae (1) and (2),...
|
|
WO/2021/202802A1 |
Embodiments of the present disclosure relate to sensors that can selectively bind to specific vicinal diols in the presence of other diols. These boronated vicinal diol-responsive sensor compounds can sense levels of specific vicinal dio...
|
|
WO/2021/196274A1 |
A fluorescent material and a synthesis method therefor. The fluorescent material has the following structural formula: (I), wherein Y is an N atom or a B atom; X1 and X2 are the same or different, and are selected from among a C atom or ...
|
|
WO/2021/191229A1 |
A method of identifying a target analyte in which a sample containing a light-emitting marker configured to bind to the target analyte is irradiated and emission from the light-emitting marker is detected. The light-emitting marker compr...
|
|
WO/2021/194216A1 |
A polycyclic aromatic compound or a condensed multimer thereof, according to the present invention, is employed in an organic layer in an organoelectroluminescent device, thereby enabling the implementation of an organoelectroluminescent...
|
|
WO/2021/191058A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic device.
|
|
WO/2021/189112A1 |
A method for detection of a nerve agent in a sample, which method comprises (a) irradiating an optical sensing element, the optical sensing element comprising a fluorescent sensing compound provided on a substrate, and measuring the lumi...
|
|
WO/2021/194298A1 |
The present invention relates to nanoparticles comprising drug dimers, and a use thereof. The nanoparticles comprising drug dimers, of the present invention, can increase drug content and improve the drug dispersibility. In addition, the...
|
|
WO/2021/191183A1 |
The invention relates to cyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2021/185829A1 |
The invention relates to heterocyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
|
|
WO/2021/187939A1 |
The present invention relates to a boron compound usable in an organic light-emitting element, and an organic light-emitting element comprising same, and more specifically, to a boron compound represented by [Chemical Formula A] and an o...
|
|
WO/2021/185712A1 |
The invention relates to heteroaromatic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
|
|
WO/2021/188700A1 |
Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agent...
|
|
WO/2021/187868A1 |
Disclosed are a compound, a photosensitizer comprising same, a composition for diagnosing or treating a tumor targeting mitochondria, and a photodynamic treatment method using the composition. The compound may be represented by the above...
|
|
WO/2021/187507A1 |
The compound represented by the general formula has excellent light-emitting characteristics and emits light having a short wavelength. Y1 is N-RA; Y2 is O, S, C=O or N-RA; RA is an aryl group, etc.; R1-R11 are hydrogen atoms or substitu...
|
|
WO/2021/182439A1 |
The purpose of the present invention is to provide: a borate compound-containing composition which is useful as a promoter for polymerization of olefins or dienes and which is soluble in a hydrocarbon solvent; and a manufacturing method ...
|
|
WO/2021/182438A1 |
The purpose of the present invention is to provide a composition containing a borate compound which is useful as a cocatalyst for the solution polymerization of olefin or diene and is soluble in a hydrocarbon solvent.　According to the ...
|
|
WO/2021/180023A1 |
The present invention provides an elastase inhibitor prodrug and use thereof. The elastase inhibitor prodrug is a compound having a structure as represented by formula I, and a pharmaceutically acceptable salt, ester, isomer, solvate, pr...
|
|
WO/2021/177390A1 |
A compound according to the present invention has a chemical structure which, when viewed macroscopically, is arranged such that a chelating portion is positioned in the center of the structure, an atomic group containing an albumin bind...
|
|
WO/2021/175183A1 |
The present invention relates to a boron carrying agent for integrated tumor diagnosis and treatment, and a preparation method therefor and use thereof. Provided is a compound represented by formula I: wherein an R group is hydrogen or a...
|
|
WO/2021/172867A1 |
The present application relates to an aluminum compound, a precursor composition for forming an aluminum-containing layer comprising the aluminum compound, and a method for forming an aluminum-containing layer by using the precursor comp...
|
|
WO/2021/170226A1 |
The invention relates to halogenated tetrasilyl boranates of general formula (I) M2+[B(SiRmXn)4-]z, wherein the groups and indices are defined as cited in claim 1, with the proviso that m+n=3, to a method for the production thereof, and ...
|
|
WO/2021/169661A1 |
The present invention belongs to the field of photodynamic anti-microbial technology, and relates to BODIPY compounds of formula (I) or (II), particularly 4-position cation double-substituted BODIPY compounds, a preparation method theref...
|
|
WO/2021/172965A1 |
The present invention relates to: a polycyclic aromatic derivative compound which can be employed in various organic layers in organic electroluminescent devices; and an organic electroluminescent device with high efficiency and long ser...
|
|
WO/2021/162347A1 |
The present invention relates to a boron compound that can be used in an organic light-emitting element, and an organic light-emitting element comprising same, and more specifically, to a boron compound represented by [chemical formula A...
|
|
WO/2021/158595A1 |
The present disclosure relates to compounds and/or compositions useful against pathogens affecting meats, plants, or plant parts. In particular, boron containing compounds are disclosed. Furthermore, the present disclosure relates to oxa...
|
|
WO/2021/153168A1 |
In this invention, the compound represented by general formula (1) is a light-emitting material having a narrow emission spectrum line width. R1 to R4 respectively represent a hydrogen atom, or a substituted or an unsubstituted alkyl gro...
|
|
WO/2021/153772A1 |
[Problem] To provide a novel blue fluorescent probe for ALDH1A1. [Solution] A compound represented by general formula (I) or a salt thereof.
|
|
WO/2021/151922A1 |
The invention relates to benzimidazole derivatives which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
|
|
WO/2021/151532A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula (I), wherein: RI, RII, RIII, RIV, RV, RVI, RVII, RVIII...
|
|
WO/2021/151822A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula I: Formula I wherein: RI, RII, RIII, RIV, RV, RVI, RVI...
|
|
WO/2021/150049A1 |
The present invention relates to a novel gadolinium-based compound having a structure in which a gadolinium complex and a gallic acid are bonded to each other, a method for producing same, and an MRI contrast agent containing same.
|
|
WO/2021/150026A1 |
The present invention relates to a polycyclic aromatic derivative compound and an organic light-emitting device having high efficiency and long lifespan, the device applying the compound in various organic layers so as to remarkably impr...
|
|
WO/2021/148786A1 |
The present invention relates to novel probe compounds of formulae I and II defined herein. The present invention also relates to methods of synthesising these novel probe compounds and to their use in assays and screens for determining ...
|
|
WO/2021/149510A1 |
By means of a pyrromethene boron complex represented by general formula (1), provided are: a light-emitting material having a high fluorescence quantum yield and a sharp light-emitting spectrum; and a light-emitting element having a high...
|
|
WO/2021/150080A1 |
A polycyclic aromatic derivative compound according to the present invention is employed in an organic layer in a device, thus being able to implement a high-efficiency organic light-emitting device, and thus can be industrially and effe...
|
|
WO/2021/150052A1 |
The present invention relates to a novel gadolinium-based compound having a structure in which a gadolinium complex and ferulic acid are linked via a linker, a preparation method therefor, and an MRI contrast agent containing same.
|
|
WO/2021/143923A1 |
Disclosed are a compound of formula (I) or pharmaceutically-acceptable salts, solvates, polymorphs or isomers thereof, and a pharmaceutical composition containing these compounds, as well as use of such compounds in treating LMP7-related...
|
|
WO/2021/146380A1 |
The present disclosure relates to novel photoluminescent complex comprising a BODIPY moiety covalently bonded to a blue light absorbing moiety, and a color conversion film, a back-light unit using the same.
|
|
WO/2021/145661A2 |
The present invention relates to a precursor compound and, more specifically, to: a precursor compound comprising a metal of Group 13 of the Periodic Table and available for thin film deposition through atomic layer deposition (ALD) or c...
|
|
WO/2021/143924A1 |
A boric acid derivative shown in formula (I) or a pharmaceutically acceptable salt, solvate, polymorph, or isomer thereof, a pharmaceutical composition containing said compounds, and a use for said compounds in the treatment of diseases ...
|
